SERVICE FOR HOSPITALS
PERSONALIZED
DIAGNOSTIC TESTS

1

CANCER BIOPSY

ARIADNE is a tool that can help doctors understand the biological features of a tumor and thus decide a personalized thrapeutic strategy

ARIADNE uses a trascriptome, representing both genetic and epigenetic components of the tumor, obtained from a bioptic sample and employs and innovative strategy based on artificial intelligence and machine learning to compute the risk aggressiveness (RA)

ARIADNE compares the transcriptome of the patient with a transcriptomic landscape obtained from the analysis of big data from breast cancer patients, particularly from specif subtypes like luminal B or triple negative

When the test is concluded, we provide a report displaying the risk of aggressiveness using a color bar going from green (negative test, low aggressiveness) to red (positive test, high aggressiveness). The doctor will then be able to assess the personalized therapy best suited for each specific case.

ARIADNE IS BASED ON CUTTING EDGE
SCIENTIFIC RESEARCH PUBLISHED
IN TOP INTERNATIONAL JOURNALS

F. Font-Clos, S. Zapperi, C.A.M. La Porta
Topography of epithelial–mesenchymal plasticity
Proceedings of the National Academy of Sciences (2018)

C.A.M. La Porta and S. Zapperi
Explaining the dynamics of tumor aggressiveness: At the crossroads between biology, artificial intelligence and complex systems

Seminars in Cancer Biology (2018)

info@complexdata.it

Copyright © 2019 Complexdata | Privacy and cookie Policy | Designed and developed by Kobold.